126 related articles for article (PubMed ID: 8558192)
1. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.
Conroy T; Etienne PL; Adenis A; Wagener DJ; Paillot B; François E; Bedenne L; Jacob JH; Seitz JF; Bleiberg H; Van Pottelsberghe C; Van Glabbeke M; Delgado FM; Merle S; Wils J
J Clin Oncol; 1996 Jan; 14(1):164-70. PubMed ID: 8558192
[TBL] [Abstract][Full Text] [Related]
2. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
3. Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.
Lacava JA; Leone BA; Machiavelli M; Romero AO; Perez JE; Elem YL; Ferreyra R; Focaccia G; Suttora G; Salvadori MA; Cuevas MA; Acuña LR; Acuña JR; Langhi M; Amato S; Castaldi J; Arroyo A; Vallejo CT
J Clin Oncol; 1997 Feb; 15(2):604-9. PubMed ID: 9053483
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
Fumoleau P; Delgado FM; Delozier T; Monnier A; Gil Delgado MA; Kerbrat P; Garcia-Giralt E; Keiling R; Namer M; Closon MT
J Clin Oncol; 1993 Jul; 11(7):1245-52. PubMed ID: 8315421
[TBL] [Abstract][Full Text] [Related]
7. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
8. Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.
Livingston RB; Ellis GK; Gralow JR; Williams MA; White R; McGuirt C; Adamkiewicz BB; Long CA
J Clin Oncol; 1997 Apr; 15(4):1395-400. PubMed ID: 9193331
[TBL] [Abstract][Full Text] [Related]
9. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival.
Conroy T; Etienne PL; Adenis A; Ducreux M; Paillot B; Oliveira J; Seitz JF; Francois E; Van Cutsem E; Wagener DJ; Kohser F; Daamen S; Praet M; Gorlia T; Baron B; Wils J;
Ann Oncol; 2002 May; 13(5):721-9. PubMed ID: 12075740
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.
Morris M; Brader KR; Levenback C; Burke TW; Atkinson EN; Scott WR; Gershenson DM
J Clin Oncol; 1998 Mar; 16(3):1094-8. PubMed ID: 9508195
[TBL] [Abstract][Full Text] [Related]
11. The activity of paclitaxel in gastrointestinal tumors.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience.
Bruno S; Puerto VL; Mickiewicz E; Hegg R; Texeira LC; Gaitan L; Martinez L; Fernandez O; Otero J; Kesselring G
Am J Clin Oncol; 1995 Oct; 18(5):392-6. PubMed ID: 7572754
[TBL] [Abstract][Full Text] [Related]
13. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
14. An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Degardin M; Oliveira J; Geoffrois L; Rolland F; Armand JP; Bastit P; Chauvergne J; Fargeot P; van Glabbeke M; Lentz MA; Tresca P; Boudillet J; Fumoleau P; Cappelaere P
Ann Oncol; 1998 Oct; 9(10):1103-7. PubMed ID: 9834823
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients.
Saeki T; Takashima S; Ogita M; Tabei T; Adachi I; Tamura K; Takatsuka Y; Kanda K
Breast Cancer; 2006; 13(2):159-65. PubMed ID: 16755111
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
[TBL] [Abstract][Full Text] [Related]
17. Vinorelbine as first-line chemotherapy for metastatic breast carcinoma.
Romero A; Rabinovich MG; Vallejo CT; Perez JE; Rodriguez R; Cuevas MA; Machiavelli M; Lacava JA; Langhi M; Romero Acuña L
J Clin Oncol; 1994 Feb; 12(2):336-41. PubMed ID: 8113840
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.
Ilson DH; Saltz L; Enzinger P; Huang Y; Kornblith A; Gollub M; O'Reilly E; Schwartz G; DeGroff J; Gonzalez G; Kelsen DP
J Clin Oncol; 1999 Oct; 17(10):3270-5. PubMed ID: 10506629
[TBL] [Abstract][Full Text] [Related]
19. Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study.
Fazeny B; Zifko U; Meryn S; Huber H; Grisold W; Dittrich C
Cancer Chemother Pharmacol; 1996; 39(1-2):150-6. PubMed ID: 8995513
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer.
Gershenson DM; Burke TW; Morris M; Bast RC; Guaspari A; Hohneker J; Wharton JT
Gynecol Oncol; 1998 Sep; 70(3):404-9. PubMed ID: 9790795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
